Skip to Main Content

Author Details

Neil B Desai
University of Texas Southwestern Medical Center
2004
65
21
PMIDPaper TitleJournal TitlePublished Year
36307013Optimizing Palliative Focal Radiation Therapy Dose in Cutaneous T-Cell Lymphoma: How Low Can You Go?Pract Radiat Oncol2023
37270247Passing the Kool-Aid Point: mRNA Expression-Based Risk Classifiers in Localized Prostate Cancer Treatment Decision Making.Int J Radiat Oncol Biol Phys2023
37474438Organ sparing treatment for penile cancer using a 3D-printed high-dose-rate brachytherapy applicator.Brachytherapy2023
36509197Preliminary Evaluation of PTV Margins for Online Adaptive Radiation Therapy of the Prostatic Fossa.Pract Radiat Oncol2023
36367998Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.J Clin Oncol2023
34774676SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial.Int J Radiat Oncol Biol Phys2022
35511691A Combined Biomarker of Bright CD38 and MYC â¿¥55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma.Am J Clin Pathol2022
35507433ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.Clin Nucl Med2022
35507413ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.Am J Clin Oncol2022
35606411Enrichment of "Cribriform" morphologies (intraductal and cribriform adenocarcinoma) and genomic alterations in radiorecurrent prostate cancer.Mod Pathol2022
35601974Primary central nervous system lymphoma: a real-world comparison of therapy access and outcomes by hospital setting.Neurooncol Pract2022
36509074NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.J Natl Compr Canc Netw2022
36046047Case Report: Adaptive radiotherapy in the radiation salvage of prostate cancer.Front Oncol2022
35993980Alterations in BRCA2 as Determinants of Therapy Response in Prostate Cancer.Crit Rev Oncog2022
35265519Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer.Front Oncol2022
34775145Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes.Transplant Cell Ther2022
33096336Dynamic differences between DNA damage repair responses in primary tumors and cell lines.Transl Oncol2021
33545689NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.J Natl Compr Canc Netw2021
33926575Combined immune checkpoint blockade and radiotherapy induces durable remission in relapsed natural killer/T-cell lymphoma: a case report and review of the literature.J Med Case Rep2021
33753140A Multi-Institutional Phase 2 Trial of High-Dose SAbR for Prostate Cancer Using Rectal Spacer.Int J Radiat Oncol Biol Phys2021
34763810PSA-Net: Deep learning-based physician style-aware segmentation network for postoperative prostate cancer clinical target volumes.Artif Intell Med2021
34646963Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma.Adv Radiat Oncol2021
34215505Metastasis-directed radiation therapy after radical cystectomy for bladder cancer.Urol Oncol2021
34195499Hydrogel Spacer Rectal Wall Infiltration Associated With Severe Rectal Injury and Related Complications After Dose Intensified Prostate Cancer Stereotactic Ablative Radiation Therapy.Adv Radiat Oncol2021
34111573A deep learning-based framework for segmenting invisible clinical target volumes with estimated uncertainties for post-operative prostate cancer radiotherapy.Med Image Anal2021
33419682The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited.Eur Urol2021
32404596ACR-ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy.Am J Clin Oncol2020
33069353Evolving Brachytherapy Boost in Prostate Cancer in the Era of Hypofractionation.Int J Radiat Oncol Biol Phys2020
30316723Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma.Brachytherapy2019
31969920Prostate brachytherapy procedural training: incorporation of related procedures in resident training and competency assessment.J Contemp Brachytherapy2019
32042635The challenge of matching assays to biology in DNA damage response biomarkers for response to radiotherapy in bladder cancer.Transl Androl Urol2019
31173917Addition of Iodinated Contrast to Rectal Hydrogel Spacer to Facilitate MRI-Independent Target Delineation and Treatment Planning for Prostate Cancer.Pract Radiat Oncol2019
31196032A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).BMC Cancer2019
31421942Salvage Radiotherapy for Nodal Oligorecurrent Prostate Cancer: A Step Towards Predictive Criteria for Metastasis-Directed Therapy in Prostate Cancer?Eur Urol2019
31277776Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate.Eur Urol Oncol2019
31109801Stereotactic Ablative Radiotherapy (SAbR) in the Setting of Metastatic Nonseminomatous Germ Cell Tumor of Testis.Clin Genitourin Cancer2019
30959121Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies.Int J Radiat Oncol Biol Phys2019
28710895Erectile function after stereotactic body radiotherapy for localized prostate cancer.BJU Int2018
29939069Rectal radiation dose-reduction techniques in prostate cancer: a focus on the rectal spacer.Future Oncol2018
29900043Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy.Oncoimmunology2018
31100248Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical Failure.Eur Urol Oncol2018
30591425Alemtuzumab is an effective third-line treatment versus single-agent gemcitabine or pralatrexate for refractory Sézary syndrome: a systematic review.Eur J Dermatol2018
29722657Patterns of Failure in Patients With Double Hit or Double Expressor Lymphomas: Implications for Radiation Therapy.Int J Radiat Oncol Biol Phys2018
29650035Image-guided radiotherapy reduces the risk of under-dosing high-risk prostate cancer extra-capsular disease and improves biochemical control.Radiat Oncol2018
29306514Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival.Eur Urol2018
29180607Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis.Clin Cancer Res2018
28581200Natural history of 'second' biochemical failure after salvage radiation therapy for prostate cancer: a multi-institution study.BJU Int2018
28008774Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.Br J Radiol2017
28139024Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study.BJU Int2017
28754673Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer Irradiation.Cancer Res2017
  • 1 - 50 of 65

Recommended Authors

Luca F Valle
University of California los angeles
Career Start Year 2016
Number of shared co-authors 24
Hilary P Bagshaw
Stanford University
Career Start Year 2014
Number of shared co-authors 16
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 18
Soumyajit Roy
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 16
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 38
Kiri A Sandler
Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 15
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 7
Ting Martin Ma
University of Washington
Career Start Year 2010
Number of shared co-authors 31
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 5
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 10
Bridget F Koontz
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 24
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 23
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 10
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 3
Mitchell Kamrava
Cedars Sinai Medical Center
Career Start Year 2005
Number of shared co-authors 9
Eyad Abu-Isa
Ascension Providence Hospital
Career Start Year 2005
Number of shared co-authors 21
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 12
Albert J Chang
University of California Los Angeles
Career Start Year 2003
Number of shared co-authors 29
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 10
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 21
Daniel J Krauss
William Beaumont School of Medicine
Career Start Year 1999
Number of shared co-authors 22
Mark K Buyyounouski
Stanford University
Career Start Year 1999
Number of shared co-authors 21
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 34
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 5
Gert De Meerleer
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 19
Constantine A Mantz
University of Chicago
Career Start Year 1997
Number of shared co-authors 16
Michael L Steinberg
University of California los angeles
Career Start Year 1996
Number of shared co-authors 37
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 13
Jeff M Michalski
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 32
Christopher R King
University of California los angeles
Career Start Year 1988
Number of shared co-authors 21

Collaborators

Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 11
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 9
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 8
William C Jackson
University of Michigan ann arbor
Co-authored papers 7
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 7
Todd M Morgan
University of Michigan ann arbor
Co-authored papers 6
Robert T Dess
University of Michigan ann arbor
Co-authored papers 6
Michael F Berger
Co-authored papers 5
Emmanuel S Antonarakis
The Sidney Kimmel Cancer Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 4
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 4
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Co-authored papers 3
Michael A Carducci
Johns Hopkins School of Medicine
Co-authored papers 3
Phuoc T Tran
University of Maryland School of Medicine
Co-authored papers 3
Simpa S Salami
University of Michigan Medical School ann arbor
Co-authored papers 3
Osama Mohamad
Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences
Co-authored papers 3
Mario A Eisenberger
Johns Hopkins University
Co-authored papers 3
Channing J Paller
Johns Hopkins University School of Medicine
Co-authored papers 3
Mark C Markowski
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 3
Chul Ahn
University of Texas Southwestern Medical Center
Co-authored papers 3
Ryan Phillips
Johns Hopkins University
Co-authored papers 2
Holly E Hartman
Case Western Reserve University
Co-authored papers 2
Tomasz M Beer
OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Amar U Kishan
University of California los angeles
Co-authored papers 2
Thomas A Hope
University of California san francisco
Co-authored papers 2
Curtiland Deville
Johns Hopkins University
Co-authored papers 2
Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
Co-authored papers 2
Elisabeth I Heath
Karmanos Cancer Center, Wayne State University
Co-authored papers 2
Prapti Patel
The University of Texas Southwestern Medical Center
Co-authored papers 2
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
Release 1.2